Eira Kelo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Eira Kelo has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Dimiter D Petkov
Laboratory of Biocatalysis, Institute of Organic Chemistry, Bulgarian Academy of Sciences, BG-1113 Sofia, Bulgaria
1 shared publication- Ilkka Mononen
Department of Clinical Chemistry and Hematology, Turku University Central Hospital, P.O. Box 52, FIN-20521 Turku, Finland
1 shared publication Ivanka B Stoineva
Laboratory of Biocatalysis, Institute of Organic Chemistry, Bulgarian Academy of Sciences, BG-1113 Sofia, Bulgaria
1 shared publication- Tiina Noronkoski
Department of Clinical Chemistry, Kuopio University Hospital, Finland
1 shared publication
Latest Publications
- 28 August 2002
- Published by Wiley in FEBS Letters
- Vol. 528 (1-3) , 130-132
β‐Aspartylpeptides as substrates of L‐asparaginases from Escherichia coli and Erwinia chrysanthemi
L‐Asparaginase is known to catalyze the hydrolysis of L‐asparagine to L‐aspartic and ammonia, but little is known about its action on peptides. When we incubated L‐asparaginases purified either from Escherichia coli or Erwinia chrysanthemi – commonly used as chemotherapeutic agents because of their antitumour activity – with eight small β‐aspartylpeptides such as β‐aspartylserineamide, β‐aspartylalanineamide, β‐aspartylglycineamide and β‐aspartylglycine, we found that both L‐asparaginases could catalyze the hydrolysis of five of them yielding L‐aspartic acid and amino acids or peptides. Our data show that L‐asparaginases can hydrolyze β‐aspartylpeptides and suggest that L‐asparaginase therapy may affect the metabolism of β‐aspartylpeptides present in human body.
- 28 August 2002
- Published by Wiley in FEBS Letters
- Vol. 528 (1-3) , 130-132
β‐Aspartylpeptides as substrates of L‐asparaginases from Escherichia coli and Erwinia chrysanthemi
L‐Asparaginase is known to catalyze the hydrolysis of L‐asparagine to L‐aspartic and ammonia, but little is known about its action on peptides. When we incubated L‐asparaginases purified either from Escherichia coli or Erwinia chrysanthemi – commonly used as chemotherapeutic agents because of their antitumour activity – with eight small β‐aspartylpeptides such as β‐aspartylserineamide, β‐aspartylalanineamide, β‐aspartylglycineamide and β‐aspartylglycine, we found that both L‐asparaginases could catalyze the hydrolysis of five of them yielding L‐aspartic acid and amino acids or peptides. Our data show that L‐asparaginases can hydrolyze β‐aspartylpeptides and suggest that L‐asparaginase therapy may affect the metabolism of β‐aspartylpeptides present in human body.